Aluminum Prices Surge Amid Iran Conflict How Major US Companies Manage Rising Costs Vickers Stock Research Releases Top Insider Picks for May 26 2026 Taiwan Chip Stocks Rise as Nvidia Unveils 150 Billion Spending Plan Chinese Chipmakers Slide Scotiabank Updates Price Target for Welltower WELL Amid Positive Outlook Dropbox CoFounder Andrew Houston to Step Down Insider Ashraf Alkarmi Named Successor Ukrainian Drone Attack Disrupts Russian Oil Export Terminal Escalates Energy Infrastructure Risks PRA Group Inc PRAA Q1 2026 Earnings EPS Surprises to the Upside Amid Limited Revenue Detail NBN Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline OGS Q1 2026 Earnings EPS Misses Expectations as Margin Pressures Mount Two Harbors Investment Corp TWO Q1 2026 Earnings Strong EPS Beat Driven by Positive Surprise CYD Q3 2020 Earnings EPS Slightly Below Estimates Stock Rises 3 CON Q1 2026 Earnings EPS Surpasses Estimates by 17 Black Spade Acquisition III Co BIII Holds Steady Near Support Amid SPAC Market Stability Inhibikase Therapeutics IKT Holds Steady at 170 as Support and Resistance Levels Tighten Northern Oil and Gas NOG Holds Steady Near Support Eyes Key Resistance Fulton Financial Preferred Stock FULTP Sees Minor Dip Holds Near Support Zone Assured Guaranty AGO Slips 226 as Market Pressure Builds on Insurance Sector General Motors Introduces AllElectric Cadillac Vistiq With 300Mile Range Gen Digital Inc GENVR Q1 2026 Earnings EPS Beat Driven by Operational Discipline SuRo Capital Holds Steady Near Support as Price Edges Higher Cameco CCJ Nears Support as Uranium Sector Faces Mixed Signals Amylyx Pharmaceuticals AMLX Edges Higher Testing Key Resistance After Modest Gain Crane Harbor Acquisition Corp II Rights CRANR Holds Steady at 022 as Market Awaits Catalysts Strategy Inc STRC Preferred Shares Hold Steady Near 9939 Key Levels in Focus Huntington Ingalls Industries HII Edges Higher Amid Defense Sector Resilience American Public Education Inc APEI Gains Ground as Shares Move Toward Key Resistance Arcutis Biotherapeutics ARQT Edges Lower as Shares Test Key Support Levels